Journal Logo

Editorial introductions

Editorial introductions

Current Opinion in Endocrinology, Diabetes and Obesity: August 2009 - Volume 16 - Issue 4 - p vii
doi: 10.1097/MED.0b013e32832e3731
  • Free

Current Opinion in Endocrinology and Diabetes was launched in 1994, with Obesity added to the title in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of endocrinology and diabetes are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

Section Editors

Peter Gottlieb

Figure 1
Figure 1

Dr Gottlieb was born in Havana, Cuba, but at age 2 moved to New Jersey where he grew up. After receiving his undergraduate degree from the University of Pennsylvania, he attended UMDNJ-Robert Wood Johnson Medical School, from which he graduated in 1984. Dr Gottlieb completed his internship and residency in internal medicine at the University of Massachusetts Medical School and then continued his fellowship training in endocrinology and metabolism there as well. In 1990, after completing his fellowship, he moved to the Weizmann Institute in Israel to do post-doctoral training in T cell immunology. After surviving Gulf War I, he returned to UMass and joined the staff as Clinical Director of Diabetes. He subsequently joined the Barbara Davis Center for Childhood Diabetes in 1995, where he is now an Associate Professor of Pediatrics and Medicine and the Director of the Translational Research Unit at the Barbara Davis Center. He has authored, co-authored and collaborated on more than 50 publications in peer-reviewed journals, as well as several book chapters and served as section editor for several journal editions. His research areas of interest include the immunology of type 1 diabetes, intervention trials to prevent or reverse type 1 diabetes, islet transplantation and the genetics of autoimmune disease. He had led several multi-center trials in new onset type 1 diabetes and is an active member of the Steering Committee for Type 1 Diabetes TrialNet, an NIH sponsored study group.

William Ludlam

Figure 2
Figure 2

Dr Ludlam is a graduate of the Albert Einstein College of Medicine in New York City where he received both his medical and graduate doctoral degrees. He completed his Internal Medicine and Endocrinology training as well as a post-doctoral fellowship in gene regulation (Vollum Institute) at the Oregon Health and Science University (OHSU) in Portland, Oregon. After completing his clinical training, Dr Ludlam continued on as a faculty member at OHSU and developed the Pituitary Unit there and served for six years as its first Director. In 2007 he relocated his practice to the Swedish Medical Center in Seattle, Washington and currently serves as the Director of the Seattle Pituitary Center. He has an active clinical practice managing patients with pituitary disorders and has a particular clinical and academic interest in patients with Cushing's disease. His clinical research interests include developing novel diagnostic and treatment options for patients with pituitary tumours and he participates in multiple national and international clinical research studies. His basic science interests are in transcriptional regulation and chromatin remodelling.

Copyright © 2009 Wolters Kluwer Health, Inc. All rights reserved.